HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,382,047 | -45.6% | 169,004 | -42.3% | 0.02% | -45.9% |
| Q1 2023 | $31,971,868 | -10.0% | 292,944 | -6.2% | 0.04% | -11.9% |
| Q4 2022 | $35,522,496 | +46.3% | 312,150 | -20.4% | 0.04% | +35.5% |
| Q3 2022 | $24,274,000 | +13.8% | 392,210 | +46.7% | 0.03% | +19.2% |
| Q2 2022 | $21,331,000 | -68.3% | 267,443 | -58.2% | 0.03% | -62.3% |
| Q1 2022 | $67,300,000 | +5.5% | 639,671 | +8.0% | 0.07% | +11.3% |
| Q4 2021 | $63,804,000 | -16.1% | 592,096 | -14.7% | 0.06% | -24.4% |
| Q3 2021 | $76,073,000 | +28.1% | 694,474 | +9.5% | 0.08% | +28.1% |
| Q2 2021 | $59,385,000 | +0.7% | 634,186 | -1.1% | 0.06% | -9.9% |
| Q1 2021 | $58,993,000 | +51.1% | 640,953 | +20.1% | 0.07% | +36.5% |
| Q4 2020 | $39,034,000 | -6.5% | 533,614 | -0.8% | 0.05% | -22.4% |
| Q3 2020 | $41,766,000 | +1.9% | 537,662 | -27.1% | 0.07% | -5.6% |
| Q2 2020 | $40,988,000 | +18.3% | 737,467 | -36.9% | 0.07% | -9.0% |
| Q1 2020 | $34,639,000 | -5.2% | 1,169,457 | +15.8% | 0.08% | +25.8% |
| Q4 2019 | $36,543,000 | +149.5% | 1,009,473 | +87.7% | 0.06% | +121.4% |
| Q3 2019 | $14,644,000 | +177.3% | 537,786 | +145.0% | 0.03% | +180.0% |
| Q2 2019 | $5,280,000 | – | 219,470 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |